Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thyroid function tests during carbimazole therapy.

D L Scott, D J Tymms, M A Taylor

    Postgraduate Medical Journal
    |December 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Scrolling, Chatting, and Posting: Longitudinal Changes in Distinct Social Media Behaviors and Their Relationship With Psychological Distress and Mental Wellbeing in Adolescents.

    Journal of adolescence·2025
    Same author

    Identifying psychological distress data available in nationally representative surveys: A scoping review and case study of Australian surveys.

    Social psychiatry and psychiatric epidemiology·2025
    Same author

    Do school-based prevention programs impact co-occurring alcohol use and psychological distress during adolescence?

    Psychological medicine·2024
    Same author

    Examining temporal trends in psychological distress and the co-occurrence of common substance use in a population-based sample of grade 7-12 students from 2013 to 2019.

    Social psychiatry and psychiatric epidemiology·2024
    Same author

    Analysis of rare disruptive germline mutations in 2135 enriched BRCA-negative breast cancers excludes additional high-impact susceptibility genes.

    Annals of oncology : official journal of the European Society for Medical Oncology·2022
    Same author

    Ischaemic preconditioning improves upper-body endurance performance without altering V̇O<sub>2</sub> kinetics.

    European journal of sport science·2022
    Same journal

    Dapagliflozin-induced anaphylactic shock.

    Postgraduate medical journal·2026
    Same journal

    Comparative efficacy of Janus kinase inhibitors in severe alopecia areata: a network meta-analysis based on randomized controlled trials.

    Postgraduate medical journal·2026
    Same journal

    Two cases of toxic epidermal necrolysis with severe ocular involvement treated with adjunctive tofacitinib.

    Postgraduate medical journal·2026
    Same journal

    Diastolic dysfunction and diabetes: the DIADAD study-a retrospective cohort study from Liverpool.

    Postgraduate medical journal·2026
    Same journal

    Care, cash, and proof: forensic accountability for war-related starvation.

    Postgraduate medical journal·2026
    Same journal

    Response to traumatic injuries in polo players in England.

    Postgraduate medical journal·2026
    See all related articles

    Plasma triiodothyronine (T3) levels are the best indicator of thyroid status in Graves' disease patients treated with carbimazole. Monitoring T3, along with sequential T4 and FT4I, provides the most accurate assessment during therapy.

    Area of Science:

    • Endocrinology
    • Internal Medicine
    • Pharmacology

    Background:

    • Graves' disease is an autoimmune disorder leading to hyperthyroidism.
    • Carbimazole is a common antithyroid medication used to manage Graves' disease.
    • Monitoring thyroid hormone levels is crucial for effective treatment adjustment.

    Purpose of the Study:

    • To investigate changes in plasma thyroxine (T4), triiodothyronine (T3), free thyroxine index (FT4I), and thyroid-stimulating hormone (TSH) during carbimazole therapy in Graves' disease patients.
    • To determine the most reliable indicator of thyroid status and treatment response.
    • To assess the utility of sequential measurements versus single-point estimations.

    Main Methods:

    • Plasma levels of T4, T3, FT4I, and TSH were measured in 100 Graves' disease patients undergoing carbimazole treatment.

    Related Experiment Videos

  • Hormone levels were analyzed to observe changes over the course of therapy.
  • Correlation between hormone levels and clinical euthyroid status was assessed.

    • Main Results:

    • During carbimazole therapy, plasma T3 concentrations were disproportionately high relative to T4, resulting in a low T4:T3 ratio.
    • Many patients achieved clinical euthyroid status with normal T3 but low T4 levels.
    • Plasma T4 levels normalized before T3 levels, with T3 emerging as the best indicator of clinical status and impending treatment changes.

    Conclusions:

    • Plasma T3 is the most sensitive marker for assessing thyroid function and predicting treatment response in Graves' disease patients on carbimazole.
    • Sequential monitoring of T4 and FT4I provides additional valuable information about thyroid status.
    • Single measurements of T4 or FT4I are insufficient for accurately assessing thyroid function during carbimazole therapy.